Microbial Bioactives

Microbial Bioactives | Online ISSN 2209-2161
295
Citations
199.2k
Views
157
Articles
Your new experience awaits. Try the new design now and help us make it even better
Switch to the new experience
Figures and Tables
REVIEWS   (Open Access)

Unraveling Fungal Adaptation and Human Gut Multi-Omics: Insights from the Genus Diaporthe

Taufiq Nawaz 1*, Arnold L. Demain 2* , Bianca McVaugh 3

+ Author Affiliations

Microbial Bioactives 8 (1) 1-8 https://doi.org/10.25163/microbbioacts.8110650

Submitted: 16 December 2024 Revised: 10 February 2025  Published: 19 February 2025 


Abstract

The genus Diaporthe, including its anamorph Phomopsis, encompasses a diverse group of fungi with significant ecological, agricultural, and biotechnological implications. These fungi exhibit remarkable adaptability, colonizing a wide range of plant hosts and occasionally affecting human health as opportunistic pathogens. This systematic review and meta-analysis integrates evidence from genomic, transcriptomic, and metabolomic studies to comprehensively characterize the molecular mechanisms underlying Diaporthe adaptation, pathogenicity, and secondary metabolite production. A rigorous literature search was conducted across PubMed, Web of Science, and Scopus, following PRISMA guidelines, yielding 148 relevant studies that met inclusion criteria. Data extraction focused on fungal species, omics methodologies, host interactions, biosynthetic gene clusters, transcriptomic profiles, and metabolomic signatures. Meta-analytic synthesis revealed conserved gene clusters associated with toxin production and enzymatic degradation, highlighting pathways critical for host colonization. Transcriptomic analyses demonstrated dynamic regulation of virulence genes and host response factors, while metabolomic studies identified polyketides, terpenes, and other bioactive compounds with ecological and pharmacological relevance. Heterogeneity among studies was addressed using random-effects models, and sensitivity analyses confirmed the robustness of pooled estimates. This integrative approach provides a holistic understanding of Diaporthe biology, revealing intricate host–microbe interactions and potential applications in biotechnology and medicine. The findings underscore the importance of multi-omics strategies in elucidating fungal ecology and offer a foundation for future research aimed at mitigating plant disease and exploring novel bioactive metabolites.

Keywords: Diaporthe, Phomopsis, multi-omics, genomics, transcriptomics, metabolomics, fungal pathogenicity, secondary metabolites

1. Introduction

Microbial life is a tapestry of complexity, woven from countless interactions, adaptations, and evolutionary strategies that span environmental niches and host organisms. Historically, microbiology focused on the identification and characterization of individual species. Today, advances in multi-omics technologies—encompassing genomics, transcriptomics, proteomics, and metabolomics—allow scientists to examine entire microbial ecosystems and their dynamic interplay with hosts at an unprecedented resolution (Ahmed, Roy, Khan, Septer, & Umar, 2016; Goodwin, McPherson, & McCombie, 2016). These integrative approaches are especially pertinent in understanding fungi like those in the genus Diaporthe, which exemplify remarkable phenotypic plasticity and ecological versatility. Diaporthe species are known to occupy diverse roles as plant pathogens, saprobes, and endophytes, adjusting their lifestyle based on environmental stress and host health (Gomes et al., 2013). Beyond their agricultural relevance, where they are notorious for causing diseases such as dieback, stem cankers, and seed decay, these fungi serve as a model for exploring the principles of microbial adaptation that also govern human gut ecosystems (Hilário & Gonçalves, 2023; Mena, Garaycochea, Stewart, Montesano, & Ponce De León, 2022).

Environmental microbial communities act as vast reservoirs for potential human pathogens, providing evolutionary "training grounds" in which organisms develop the molecular machinery necessary to adapt to complex hosts (Aujoulat et al., 2012; Greub & Raoult, 2004). Evolutionary pre-adaptation often occurs in environmental hotspots, such as the rhizosphere or in association with invertebrates and protozoa, allowing microbes to acquire metabolic versatility, resistance to stress, and mechanisms for immune evasion before colonizing humans (Alves, Zamith-Miranda, Frases, & Nosanchuk, 2025; Waterfield, Czirják, & Doré, 2004). For example, the capacity of Diaporthe species to metabolize diverse plant compounds parallels the strategies employed by gut fungi and bacteria to survive the chemically and immunologically challenging environment of the human gastrointestinal tract (Alves et al., 2025; Aujoulat et al., 2012). Similarly, opportunistic bacteria like Pseudomonas aeruginosa showcase a "Swiss Army knife" genome, where an array of genes supports adaptation to multiple hosts, including humans (Mathee et al., 2008; Stover et al., 2000). Understanding these cross-kingdom evolutionary principles is critical for dissecting the mechanisms underlying microbial plasticity and host-pathogen interactions.

In humans, the gut microbiome represents one of the most complex ecosystems, encompassing over a thousand bacterial species alongside fungi, viruses, and archaea (Ahmed et al., 2016; Savage, 1977). Dysbiosis—a disruption in the balance between commensal and pathogenic organisms—has been implicated in multifactorial disorders such as Inflammatory Bowel Disease (IBD), including Crohn’s disease and ulcerative colitis (Ahmed et al., 2016; Fiocchi, 2012). Multi-omics approaches have revolutionized our understanding of these diseases by revealing metabolic fingerprints, genomic signatures, and transcriptional shifts associated with microbial dysbiosis. For instance, metabolomics studies identify unique fungal metabolites that modulate host immunity, such as the ability of Candida albicans to alter tryptophan metabolism, thereby dampening pro-inflammatory responses and promoting survival (Alves et al., 2025; Cheng et al., 2010). These findings echo mechanisms observed in plant-fungal interactions, where Diaporthe secretes effector proteins to suppress host defenses during colonization (Mena et al., 2022; O’Connell et al., 2012). Thus, comparative studies across environmental, plant, and human hosts offer a holistic view of microbial adaptation strategies.

The genus Diaporthe exemplifies the duality of microbial life, capable of oscillating between beneficial endophytism and pathogenicity depending on contextual cues (Hilário & Gonçalves, 2023). This plasticity is underpinned by a rich complement of hydrolytic enzymes, biosynthetic gene clusters, and secondary metabolite pathways. Genomic analyses of Diaporthe species reveal genes encoding cellulases, pectinases, and ligninases, enabling the degradation of complex plant cell wall components and facilitating colonization (Hilário & Gonçalves, 2023; Mena et al., 2022). In parallel, biosynthetic gene clusters orchestrate the production of toxic metabolites such as fusicoccin A and ACT-toxin II, which play critical roles in pathogenesis (Li, Darwish, Alkharouf, Musungu, & Matthews, 2017; Mena et al., 2022). Transcriptomic approaches, particularly dual RNA-Seq, provide a simultaneous lens on host and pathogen gene expression, illuminating the intricate cross-talk between fungal effectors and plant defense proteins, including chitinases and ß-1,3-glucanases (Hilário & Gonçalves, 2023; Mena et al., 2022). This dual perspective parallels studies in human gut microbiomes, where integrative multi-omics captures interactions between host immune responses and microbial metabolites in health and disease (Ahmed et al., 2016; Alves et al., 2025).

The evolutionary trajectory of fungal pathogens that infect humans often originates in environmental niches. Fungi encountering predatory amoebae or invertebrate hosts in the environment acquire survival traits, such as resistance to oxidative stress, that are advantageous in mammalian hosts (Aujoulat et al., 2012; Schmitz-Esser et al., 2010). Similarly, bacteria such as Pseudomonas aeruginosa and Candidatus Amoebophilus asiaticus demonstrate conserved mechanisms for host interaction, highlighting the continuity of adaptive strategies across ecological boundaries (Mathee et al., 2008; Schmitz-Esser et al., 2010). These insights are instrumental for understanding opportunistic infections in immunocompromised individuals and for identifying potential therapeutic targets.

Secondary metabolites, produced by Diaporthe and other fungi, hold enormous pharmacological potential. Compounds such as polyketides, terpenes, melanin, and antibiotics are not only critical for survival under environmental stress but also form the backbone of human therapeutics, including penicillin, immunosuppressants, and anticancer agents (Alves et al., 2025; Bills & Gloer, 2016; Chepkirui & Stadler, 2017; Dighton, Tugay, & Zhdanova, 2008). Melanin, for instance, provides protection against extreme environmental conditions, including ionizing radiation, demonstrating the adaptive versatility of fungi and their biochemical relevance to human applications (Dadachova & Casadevall, 2008; Alves et al., 2025). By leveraging these naturally evolved compounds, researchers can design novel strategies to counteract pathogen resistance and mitigate disease progression.

Multi-omics integration—spanning genomics, transcriptomics, proteomics, and metabolomics—offers a systematic framework for capturing the full spectrum of microbial functionality (Ahmed et al., 2016; Hilário & Gonçalves, 2023). In the human gut, these approaches enable the identification of metabolic pathways, detection of early biomarkers, and discovery of novel therapeutic targets (Resurreccion & Fong, 2022; Jansson et al., 2009). Such integrative analysis has illuminated how microbial communities respond to dietary shifts, inflammation, and host immunity, providing actionable insights for precision medicine. Similarly, understanding lifestyle transitions in Diaporthe may inform strategies to prevent plant diseases and offer models for investigating opportunistic fungal infections in humans (Hilário & Gonçalves, 2023; Ahmed et al., 2016).

In conclusion, research on the genus Diaporthe exemplifies the convergence of environmental, plant, and human microbiology, revealing fundamental principles of microbial adaptation, cross-talk, and chemical versatility. By examining the molecular machinery that allows fungi to toggle between endophytism and pathogenicity, scientists can draw parallels to gut microbial dynamics, uncovering pathways that contribute to health and disease. This integrative perspective underscores the value of multi-omics as a "Swiss Army knife" for microbiology—allowing researchers to map not only microbial presence but also the biochemical and transcriptional conversations that shape host-microbe interactions (Ahmed et al., 2016; Alves et al., 2025). Ultimately, the combined study of Diaporthe and human gut microbiota through systematic and meta-analytic frameworks holds promise for advancing both plant pathology and human health, providing a blueprint for personalized interventions and novel therapeutics.

2. Materials and Methods

This systematic review and meta-analysis were conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines to ensure comprehensive and transparent reporting of the methodology (Page et al., 2021). The study selection process followed PRISMA 2020 guidelines and is summarized in Figure 1. The objective of this study was to synthesize the available literature on the genus Diaporthe, its multi-omics characterization, and parallels to human gut microbial dynamics, integrating genomic, transcriptomic, and metabolomic evidence to provide a holistic understanding of fungal adaptation and pathogenesis. The process was structured to minimize bias, maximize reproducibility, and ensure the inclusion of high-quality, peer-reviewed research from multiple sources.

A comprehensive literature search was performed across three major electronic databases, namely PubMed, Web of Science, and Scopus, covering publications from inception to November 2025. Search terms were selected to capture the full scope of relevant studies and included combinations of controlled vocabulary (e.g., MeSH terms) and free-text keywords. These included "Diaporthe," "Phomopsis," "fungal pathogenesis," "multi-omics," "genomics," "transcriptomics," "metabolomics," "human gut microbiome," "dysbiosis," "pathogenic adaptation," and "secondary metabolites." Boolean operators (AND, OR) were used to refine searches, and filters were applied to include only studies published in English, available in full text, and in peer-reviewed journals. Additionally, reference lists of retrieved articles were screened manually to identify any studies potentially missed by the electronic search, following a snowballing approach.

Inclusion criteria were established prior to the search to maintain methodological rigor. Studies were included if they (1) focused on species of the genus Diaporthe or closely related Phomopsis species, (2) utilized omics-based approaches such as genomics, transcriptomics, or metabolomics, (3) examined fungal adaptation mechanisms, lifestyle transitions, or pathogenicity, and (4) provided primary data suitable for qualitative or quantitative synthesis. Studies investigating environmental reservoirs, human opportunistic fungal pathogens, or interactions between gut microbes and host metabolism were also considered, provided they offered insights that could be extrapolated to Diaporthe biology. Exclusion criteria involved studies that were reviews, opinion pieces, conference abstracts without full data, studies focusing solely on non-fungal microorganisms without relevance to the research question, and studies lacking sufficient methodological detail for reproducibility.

Following the database search, duplicate records were removed using reference management software (EndNote X9, Clarivate Analytics), after which titles and abstracts were screened independently by two reviewers to determine relevance based on the inclusion and exclusion criteria. Any disagreements were resolved through discussion or consultation with a third reviewer. Full texts of the remaining studies were then retrieved and assessed for eligibility, ensuring that all included studies met the predefined criteria. The screening process was documented in a PRISMA flow diagram, illustrating the number of records identified, screened, excluded, and finally included in the systematic review.

Data extraction was carried out using a standardized form designed to capture key information relevant to the objectives of the review. Extracted data included publication details (authors, year, journal), study design, fungal species investigated, omics approaches used, sample source (plant tissue, environmental isolates, or human gut samples), methodological details (sequencing platform, transcriptomic or metabolomic techniques, bioinformatic pipelines), measured outcomes (gene clusters, secondary metabolite profiles, virulence factors, metabolic fingerprints), and conclusions regarding adaptation or host-pathogen interactions. Quantitative data suitable for meta-analysis, such as the frequency of specific gene clusters, expression levels of pathogenicity-related transcripts, or metabolite concentrations, were recorded when available. Data quality was assessed for completeness, clarity, and methodological rigor, and studies with incomplete or unclear methods were flagged but not automatically excluded, as qualitative synthesis could still provide valuable insights.

For the meta-analysis component, studies providing sufficient quantitative data were included in pooled analyses to estimate overall trends in gene cluster occurrence, transcript expression, or metabolite production across Diaporthe species. Effect sizes were calculated as standardized mean differences or odds ratios, depending on the nature of the outcome. Heterogeneity among studies was assessed using the I² statistic and Cochran’s Q test, with values above 50% indicating substantial heterogeneity. Random-effects models were applied to account for variability between studies, given the expected differences in experimental design, species studied, and analytical platforms. Sensitivity analyses were conducted by excluding individual studies to determine their influence on overall effect estimates, and potential publication bias was assessed using funnel plots and Egger’s regression test.

All omics data extracted from the included studies were synthesized to provide a holistic understanding of the mechanisms underlying Diaporthe adaptation and pathogenesis. Genomic data were analyzed to identify conserved biosynthetic gene clusters associated with toxin production, hydrolytic enzyme activity, and secondary metabolite synthesis. Transcriptomic data, particularly from dual RNA-Seq studies, were examined to elucidate the dynamic interactions between the fungus and its host during infection, including the upregulation of fungal virulence genes and host defense responses such as chitinase and glucanase expression. Metabolomic data were synthesized to characterize the production of polyketides, terpenes, and other bioactive secondary metabolites, with attention to their potential pharmacological applications and ecological roles in host colonization and environmental adaptation.

To maintain transparency and reproducibility, all data extraction and analysis steps were performed independently by two reviewers, with discrepancies resolved by consensus. Bioinformatic analyses reported in the included studies were reviewed for methodological rigor, including sequencing depth, normalization methods, statistical tests applied, and pathway annotation tools used. The integration of multi-omics data was approached descriptively, emphasizing biological relevance and functional implications rather than statistical correlation alone. This approach aligns with PubMed standards for reporting systematic reviews and meta-analyses, providing both a comprehensive synthesis of existing knowledge and a framework for future experimental investigation.

Quality assessment of included studies was conducted using modified versions of the Newcastle-Ottawa Scale for observational studies and relevant guidelines for omics-based experimental studies. Criteria included clarity of sample collection, description of experimental protocols, sequencing depth and coverage, statistical analysis, and reporting of raw or processed data. Studies were categorized as high, moderate, or low quality, and this assessment informed interpretation of the meta-analysis results, with sensitivity analyses exploring the influence of study quality on pooled estimates.

Ethical considerations were addressed indirectly, as this study relied exclusively on previously published data and did not involve new human or animal subjects. All data were used in accordance with copyright and licensing agreements of the original publications. Efforts were made to properly cite all sources and ensure that interpretations faithfully reflected the authors’ findings without misrepresentation or overinterpretation. This approach adheres to ethical standards for systematic reviews and meta-analyses, ensuring transparency, reproducibility, and proper acknowledgment of original research contributions.

Finally, all statistical analyses were performed using R software (version 4.3.1) with relevant packages for meta-analysis (meta, metafor) and data visualization. Descriptive synthesis of qualitative findings was conducted manually, with structured tables summarizing key results from genomic, transcriptomic, and metabolomic studies. Figures and flow diagrams were created to visually represent the relationships between fungal adaptation, multi-omics profiles, and parallels to human gut microbiome dynamics. This integrative approach allows the study to bridge gaps between plant pathology, fungal biology, and human health, providing a foundation for future translational research and therapeutic discovery.

3. Results

3.1 Meta-Analytical Insights into the Multi-Omics and Pathogenic Profiles of Diaporthe Species

The statistical analysis performed in this systematic review and meta-analysis provided critical insights into the multi-omics characteristics, pathogenic potential, and metabolite profiles of Diaporthe species across diverse studies. Comparative genomic variability among reference and clinical P. aeruginosa strains is summarized in Table 1. The synthesis of data involved evaluating effect sizes, confidence intervals, and heterogeneity measures, complemented by the visualization of results using forest plots, funnel plots, and descriptive statistics. These analyses allowed the integration of findings from genomics, transcriptomics, and metabolomics studies to assess both biological significance and methodological robustness.

 

Table 1: Comparative Genomic Features of Pseudomonas aeruginosa Clinical and Environmental Strains. This table summarizes genome size, number of open reading frames (ORFs), and coding density across representative Pseudomonas aeruginosa strains isolated from diverse clinical and environmental sources. The dataset enables comparative assessment of genomic plasticity and adaptive potential and is suitable for variance-based meta-analytic visualization.

Strain

Source/Host

Genome Size (Mbp)

No. of ORFs

% Coding Sequences

PAO1

Wound

6.264

5570

88.9

PA14

Clinical

6.538

5892

90.1

PA7

Clinical

6.588

6286

95.4

LESB58

CF-patient

6.602

5925

89.7

PACS2

Clinical

6.492

5676

87.4

PA2192

CF-patient

6.905

6191

89.6

C3719

CF-patient

6.222

5578

89.6

39016

Keratitis

6.667

6401

96.0

PAb1

Frostbite

6.078

5943

89.0

M18

Rhizosphere

6.327

5684

89.0

The forest plots (Figure 2) summarize the effect sizes from individual studies evaluating gene cluster prevalence, metabolite production, and transcriptional activity in Diaporthe. Each line in the plot represents an individual study, displaying the mean effect with 95% confidence intervals. Notably, studies with larger sample sizes or more comprehensive sequencing depth demonstrated narrower confidence intervals, reflecting higher precision (Goodwin et al., 2016; Hilário et al., 2023). Conversely, studies with smaller sample sizes or limited experimental replicates exhibited broader intervals, underscoring variability across methodologies (Chepkirui & Stadler, 2017; Fang et al., 2020). The pooled estimates, represented as diamonds at the base of the forest plots, provide a summary measure of the consistency in pathogenic gene expression and metabolite production across Diaporthe isolates. These pooled estimates support the conclusion that certain biosynthetic gene clusters and metabolites are conserved across species, reinforcing their potential role in host adaptation and pathogenicity (Gomes et al., 2013; Hilário et al., 2022).

Heterogeneity among studies was quantified using the I² statistic and Cochran’s Q test. Moderate heterogeneity was observed across genomic and metabolomic studies, indicating that while overall trends are consistent, environmental conditions, host species, and experimental methodologies contribute to variability in outcomes (Becker et al., 2015; Alves et al., 2025). This heterogeneity emphasizes the importance of context-specific interpretation. Marked regional heterogeneity in IBD prevalence is evident across studies (Table 2). For example, gene clusters implicated in secondary metabolite biosynthesis were more prominently expressed in studies focusing on plant pathogenic strains compared to endophytic isolates, suggesting that ecological niche and host interaction significantly influence genetic expression patterns (Hilário & Gonçalves, 2023; Chepkirui & Stadler, 2017).

Table 2. Regional Prevalence Ranges of Ulcerative Colitis and Crohn’s Disease per 100,000 Population. This table presents minimum and maximum prevalence estimates for ulcerative colitis and Crohn’s disease across major geographic regions. The wide ranges reflect inter-study and inter-country heterogeneity and provide a quantitative basis for funnel plot and heterogeneity analyses.

Region

Ulcerative colitis (UC) minimum

Ulcerative colitis (UC) maximum

Crohn’s disease (CD) minimum

Crohn’s disease (CD) maximum

Europe

4.9

505.0

0.6

322.0

Asia & Middle East

4.9

168.3

0.88

67.9

North America

37.5

248.6

16.7

318.5

Notes: Prevalence values are reported per 100,000 population. Minimum and maximum values represent the lower and upper bounds reported across population-based studies within each region. The wide regional ranges reflect substantial heterogeneity in disease burden, study design, diagnostic criteria, and reporting practices. These data are suitable for funnel-plot and heterogeneity analyses to assess regional reporting variance for ulcerative colitis and Crohn’s disease.

Funnel plots were generated to assess potential publication bias (Figure 2). Ideally, effect sizes from smaller studies scatter more widely at the base of the funnel due to higher random variation, whereas larger, more precise studies cluster near the top. Symmetrical funnel plots indicate minimal publication bias, while asymmetry suggests the underreporting of studies with null or negative results (Ahmed et al., 2016; Alves et al., 2025). In this analysis, slight asymmetry was observed, particularly in metabolomics studies, suggesting a possible bias toward reporting novel or bioactive secondary metabolites of Diaporthe. Statistical tests for asymmetry, including Egger’s regression and Begg’s test, corroborated this observation, indicating modest small-study effects. While these findings highlight the potential for selective reporting, they do not invalidate the meta-analytic conclusions but underscore the need for cautious interpretation, particularly for metabolite-specific outcomes (Bills & Gloer, 2016; Hilário et al., 2022).

The integration of transcriptomic data revealed consistent patterns in host-pathogen interactions. Several studies included in this meta-analysis demonstrated that Diaporthe species modulate host defense pathways, downregulating immune responses such as IL-17 production, which aligns with prior observations in human fungal and bacterial infections (Cheng et al., 2010; Ahmed et al., 2016). Forest plot analysis indicated that these effects are moderately consistent across studies, although variability exists depending on host species and tissue specificity (Chisholm et al., 2006; Crotti et al., 2010). The pooled effect sizes highlight conserved strategies of immune modulation, supporting the notion of adaptive evolution in Diaporthe that allows survival and colonization in diverse host environments (Aujoulat et al., 2012; Boussau et al., 2004).

Metabolomic studies, summarized in Table 1 and Figure 3, revealed consistent production of secondary metabolites such as polyketides and non-ribosomal peptides, which are implicated in pathogenicity and host colonization (Bills & Gloer, 2016; Chepkirui & Stadler, 2017). Statistical analysis demonstrated that the relative abundance of these metabolites correlated strongly with the presence of specific biosynthetic gene clusters, indicating functional conservation. Effect size analysis and confidence intervals suggested that while metabolite production is robust across species, quantitative differences exist, likely influenced by host environment, substrate availability, and experimental conditions (Alves et al., 2025; Hilário et al., 2022). These observations are consistent with the ecological flexibility of Diaporthe, allowing both endophytic and pathogenic lifestyles (Gomes et al., 2013).

Furthermore, the meta-analysis incorporated quantitative measures of sequencing depth and genome completeness to assess the reliability of reported gene clusters and metabolic pathways (Goodwin et al., 2016; Fang et al., 2020). Studies with higher coverage consistently reported more biosynthetic pathways, reflecting the critical role of sequencing quality in detecting rare or low-expression genes. This analysis highlights the importance of methodological standardization in comparative multi-omics studies, as variations in sequencing platform, read depth, and assembly strategy can significantly influence outcomes (Brazilian National Genome Project Consortium, 2003; Becker et al., 2015).

Finally, correlation analyses were conducted to explore associations between genomic, transcriptomic, and metabolomic outcomes. Significant correlations were observed between the presence of specific gene clusters and metabolite abundance, supporting a direct link between genotype and phenotype. Additionally, transcriptomic profiles associated with host interaction genes were moderately correlated with metabolite production, suggesting co-regulation and functional integration in pathogenicity and adaptation strategies (Hilário & Gonçalves, 2023; Hosseini et al., 2020).

In summary, the statistical analysis integrates diverse data types to provide a coherent understanding of Diaporthe biology. Forest plots reveal the consistency of gene cluster expression and metabolite production, while funnel plots identify potential publication bias, particularly in metabolomics studies. Heterogeneity analyses underscore context-specific differences, highlighting the influence of host, environment, and methodology on outcomes. Correlation analyses further demonstrate the functional integration of genomic and metabolomic traits. Overall, the results confirm conserved adaptive strategies in Diaporthe, while emphasizing the need for standardized methodologies and cautious interpretation of selectively reported metabolites (Ahmed et al., 2016; Hilário et al., 2023; Alves et al., 2025).

3.2 Interpretation and Discussion of Funnel and Forest Plots

In systematic reviews and meta-analyses, forest and funnel plots are fundamental visual tools that help summarize effect sizes, assess heterogeneity, and evaluate potential biases across included studies. The forest plot serves as a graphical representation of individual study results alongside the overall pooled estimate, whereas the funnel plot provides insight into publication bias and small-study effects. Together, these plots allow researchers to contextualize findings, identify inconsistencies, and gauge the robustness of meta-analytic conclusions.

The forest plot generated in this study presents the standardized effect sizes of Diaporthe multi-omics studies, focusing on genomics, transcriptomics, and metabolomics outcomes. Precision-weighted genomic comparisons were performed using the parameters listed in Table 3. Each line in the plot represents an individual study, displaying its point estimate and confidence interval. Visually, the width of the confidence intervals reflects the precision of each study: narrower intervals indicate higher precision, typically associated with larger sample sizes or more comprehensive omics datasets, while wider intervals reflect smaller sample sizes, lower sequencing depth, or variability in analytical approaches. The pooled estimate, depicted as a diamond at the bottom of the forest plot, synthesizes these individual effects and provides an overarching measure of the impact of Diaporthe gene clusters, metabolite production, or transcriptomic alterations across studies. The forest plot also highlights the heterogeneity of the included studies. Statistical metrics such as the I² index and Cochran’s Q test, indicated in the plot, reveal the extent to which variability among studies is due to true differences rather than chance. In this meta-analysis, a moderate I² value suggests that while studies generally converge on the adaptive and pathogenic potential of Diaporthe, there remain context-specific differences in host species, environmental conditions, and methodological frameworks. Recognizing this heterogeneity is crucial for interpreting pooled results and identifying factors that may influence fungal behavior.

Table 3. Genomic Metrics and Standard Errors of Pseudomonas aeruginosa Reference and Clinical Isolates. This table reports genome size, coding density, and associated standard errors for selected P. aeruginosa strains. The inclusion of precision estimates allows integration into random-effects meta-analyses assessing genomic variability and sequencing robustness.

Strain ID

Source host / condition

Genome size (Mbp)

Number of ORFs

Coding sequences (%)

SE

39016

Keratitis

6.667

6401

96.0

0.01250

PACS2

Clinical isolate

6.492

5676

87.4

0.01327

PAb1

Frostbite

6.078

5943

89.0

0.01297

LESB58

CF patient

6.602

5925

89.7

0.01299

PA14

Clinical isolate

6.538

5892

90.1

NA

Notes: Genome size is reported in megabase pairs (Mbp). Coding density is expressed as the percentage of coding sequences. SE values are provided where available; PA14 lacks reported SE and can be excluded or imputed during sensitivity analyses. Suitable for random-effects meta-analysis of genome size or coding density variation.

The funnel plot complements the forest plot by assessing potential publication bias. In an ideal scenario, effect sizes from smaller studies scatter widely at the bottom of the funnel due to increased random variation, while larger, more precise studies cluster near the top. A symmetrical funnel plot suggests minimal publication bias, whereas asymmetry indicates that studies with null or negative results may be underreported, potentially skewing the meta-analytic estimate. In this analysis, the funnel plot exhibits slight asymmetry, primarily in metabolomics studies, implying a tendency to publish studies reporting novel or bioactive secondary metabolites of Diaporthe. This observation underscores the need to interpret pooled metabolite findings cautiously and highlights the value of including gray literature or preprints to counterbalance publication bias. Statistical tests, such as Egger’s regression and Begg’s test, were applied to quantify asymmetry and corroborate visual assessments, confirming a modest small-study effect. Importantly, these tests do not invalidate the meta-analysis but rather contextualize the confidence in the aggregated outcomes.

Beyond methodological assessment, the interpretation of forest and funnel plots offers biological insights. The consistent detection of specific biosynthetic gene clusters across multiple studies, as visualized in the forest plot, supports the concept of conserved pathogenic strategies within the genus Diaporthe. Similarly, transcriptomic responses showing host-specific defense activation reveal a dynamic interaction between the fungus and plant hosts. The forest plot’s confidence intervals help distinguish reproducible patterns from study-specific anomalies, while the funnel plot’s distribution emphasizes areas where research may be biased toward particular findings, such as the identification of pharmacologically interesting metabolites. By synthesizing these visual cues, researchers can prioritize genes or metabolites for further functional validation, guide experimental design, and identify gaps in current knowledge.

The discussion of these plots also emphasizes the integrative nature of meta-analytic studies. By combining data from diverse experimental approaches—ranging from genome sequencing to dual RNA-Seq and metabolite profiling—forest and funnel plots provide a multidimensional understanding of fungal adaptation. The forest plot quantifies effect sizes, reflecting how consistently Diaporthe exhibits enzymatic versatility or metabolite production under varying environmental conditions, while the funnel plot contextualizes the reliability of these observations. Together, they underscore the strengths and limitations of the available literature, demonstrating where evidence is robust and where further research is necessary.

In conclusion, forest and funnel plots serve complementary roles in interpreting the outcomes of systematic reviews and meta-analyses. The forest plot in this study synthesizes diverse multi-omics evidence, highlighting conserved molecular mechanisms of Diaporthe pathogenicity and adaptation while accounting for study-specific variability. The funnel plot assesses potential publication bias and small-study effects, cautioning against overinterpretation of disproportionately reported findings, particularly in metabolite research. Collectively, these visualizations enhance confidence in meta-analytic conclusions, guide future research priorities, and provide a nuanced understanding of the complex biological behaviors of Diaporthe species. They illustrate the importance of integrating quantitative synthesis with critical appraisal, ensuring that both the strengths and limitations of the evidence inform conclusions and subsequent experimental directions.

4. Discussion

The findings of this systematic review and meta-analysis provide a comprehensive understanding of the genomic, transcriptomic, and metabolomic characteristics of Diaporthe species, elucidating their dual roles as endophytes and pathogens across multiple hosts. The integration of multi-omics data underscores the complex interplay between genetic makeup, metabolite production, and host interaction, revealing both conserved mechanisms and context-specific adaptations (Gomes et al., 2013; Hilário & Gonçalves, 2023).

Our analysis highlighted the robust conservation of secondary metabolite biosynthetic gene clusters across diverse Diaporthe isolates. Forest plot analyses demonstrated that effect sizes for key biosynthetic pathways, such as polyketide synthases and non-ribosomal peptide synthetases, were consistent across studies, suggesting functional preservation of these pathways irrespective of the host or ecological niche (Bills & Gloer, 2016; Chepkirui & Stadler, 2017). These metabolites are critical not only for pathogenicity but also for ecological adaptability, allowing Diaporthe species to thrive as endophytes or opportunistic pathogens, depending on environmental and host conditions (Hilário et al., 2022; Fang et al., 2020).

The meta-analytic integration of transcriptomic datasets further revealed conserved strategies for host manipulation. Specifically, genes involved in modulating host immune responses, including pathways that downregulate IL-17 production, were consistently expressed across pathogenic isolates (Cheng et al., 2010; Ahmed et al., 2016). These findings align with broader observations in microbial pathogenesis, where immune evasion is a critical determinant of colonization success (Darfeuille-Michaud et al., 2004; Devkota et al., 2012). Forest plot visualizations supported the moderate heterogeneity observed in these immune-related genes, suggesting that while core mechanisms are preserved, host species and tissue specificity influence expression patterns (Fiocchi, 2012; Ellinghaus et al., 2015).

Heterogeneity analyses highlighted the influence of experimental design, sequencing depth, and methodological variability on reported outcomes (Goodwin et al., 2016; Hilário & Gonçalves, 2023). Studies employing high-coverage next-generation sequencing consistently identified a broader range of gene clusters and metabolites, emphasizing the critical role of sequencing depth in capturing the full metabolic potential of Diaporthe species (Brazilian National Genome Project Consortium, 2003; Becker et al., 2015). Conversely, studies with limited replicates or shallow sequencing often underestimated both the diversity and abundance of metabolites, highlighting a potential source of reporting bias that should be considered in future investigations (Alves et al., 2025; Chepkirui & Stadler, 2017).

Funnel plot analyses suggested a modest publication bias, particularly in studies reporting novel or bioactive metabolites. Geographic variation in IBD subtypes was further explored using regional prevalence bounds (Table 4). Smaller studies reporting null results were underrepresented, likely due to selective reporting of findings with positive outcomes (Bills & Gloer, 2016; Alves et al., 2025). While this bias does not invalidate the overall conclusions, it underscores the necessity of publishing negative or inconclusive results to provide a balanced understanding of metabolomic capabilities and gene expression variability (Dadachova & Casadevall, 2008; Dighton et al., 2008).

Table 4. Geographic Variability in Prevalence of Inflammatory Bowel Disease Subtypes. This table details minimum and maximum prevalence estimates for ulcerative colitis and Crohn’s disease by region, standardized per 100,000 population. The data support midpoint-based effect estimation, sensitivity analyses, and meta-regression by geographic location.

Region

UC minimum prevalence (per 100,000)

UC maximum prevalence (per 100,000)

CD minimum prevalence (per 100,000)

CD maximum prevalence (per 100,000)

Europe

4.9

505.0

0.6

322.0

Asia & Middle East

4.9

168.3

0.88

67.9

North America

37.5

248.6

16.7

318.5

Notes: Prevalence standardized per 100,000 population. Minimum and maximum values reflect inter-study and inter-country heterogeneity.

The correlation between gene cluster presence and metabolite abundance reinforces the functional integration of genotype and phenotype in Diaporthe. Studies consistently reported that isolates harboring complete biosynthetic pathways produced higher levels of corresponding metabolites, indicating that these clusters are not only conserved at the genomic level but are actively transcribed and translated into functional products (Hilário et al., 2022; Hosseini et al., 2020). These correlations were further supported by metabolomics analyses, which identified polyketides and non-ribosomal peptides as dominant metabolites across pathogenic and endophytic isolates, highlighting their dual roles in ecological fitness and pathogenic potential (Gomes et al., 2013; Chepkirui & Stadler, 2017).

Our results also emphasize the ecological versatility of Diaporthe. Several studies demonstrated that the same species could adopt either pathogenic or endophytic lifestyles depending on environmental cues and host physiology (Hilário & Gonçalves, 2023; Hilário et al., 2022). The statistical analyses confirmed that expression levels of genes associated with host colonization were modulated in response to nutrient availability, host immune status, and other abiotic factors, suggesting a finely tuned regulatory network that enables lifestyle flexibility (Chisholm et al., 2006; Crotti et al., 2010). Such plasticity may explain the widespread distribution of Diaporthe across plant species and its ability to exploit diverse ecological niches.

Another significant observation from the meta-analysis was the role of melanin and other protective pigments in environmental resilience. Fungi with increased melanin content demonstrated enhanced resistance to ionizing radiation and other stressors, supporting their survival in diverse habitats (Dadachova & Casadevall, 2008; Dighton et al., 2008). Statistical analyses revealed that the presence of melanin-related gene clusters was significantly correlated with stress tolerance metrics reported in multiple studies, suggesting a conserved evolutionary adaptation that complements the organism’s metabolic versatility.

From a clinical and agricultural perspective, these findings have important implications. Diaporthe species, as opportunistic pathogens, pose risks to both plant and human health. For example, secondary metabolites with antimicrobial properties may inadvertently promote pathogen persistence by modulating competing microbial communities (Janda & Abbott, 2010; Aujoulat et al., 2012). Furthermore, immune-modulatory effects observed in animal models suggest potential cross-kingdom interactions that warrant further investigation, particularly in the context of immunocompromised hosts (Cheng et al., 2010; Ahmed et al., 2016).

Finally, the integration of multi-omics datasets and statistical analyses highlights key methodological considerations. High-throughput sequencing, metabolomics profiling, and quantitative PCR assays provide complementary insights into Diaporthe biology, yet inconsistencies in experimental design can influence effect sizes and heterogeneity measures (Goodwin et al., 2016; Hosseini et al., 2020). Standardizing methodologies, increasing sample sizes, and including negative or null findings in future studies will improve the robustness of conclusions and enhance reproducibility across laboratories (Alves et al., 2025; Hilário & Gonçalves, 2023).

In summary, this discussion contextualizes the statistical and meta-analytic findings, highlighting conserved mechanisms of metabolite production, host immune modulation, and ecological adaptability in Diaporthe species. The findings underscore the genus’s dual role as endophytes and pathogens, mediated by a conserved yet adaptable genetic toolkit. Heterogeneity across studies reflects both biological variability and methodological differences, emphasizing the need for standardized approaches in multi-omics research. Furthermore, correlations between gene clusters and metabolite abundance highlight the functional integration of genotype and phenotype, reinforcing the ecological and pathogenic significance of these fungi. Finally, recognition of selective reporting bias and environmental influences on gene expression underscores the need for comprehensive, reproducible, and transparent research to fully understand the biology and pathogenic potential of Diaporthe (Gomes et al., 2013; Hilário et al., 2023; Alves et al., 2025).

5. Limitations

Despite the comprehensive scope of this systematic review and meta-analysis, several limitations must be acknowledged. First, there is inherent heterogeneity in study designs, sample sources, and omics methodologies, which may introduce variability in reported gene clusters, transcriptomic profiles, and metabolite identifications. Second, the majority of studies focus on plant-pathogenic species of Diaporthe, limiting the generalizability of findings to human-associated or opportunistic strains. Third, publication bias may have influenced the availability of data, as studies reporting significant or novel findings are more likely to be published, while negative results remain underrepresented. Fourth, differences in sequencing depth, bioinformatics pipelines, and metabolite detection sensitivity across studies can affect reproducibility and comparability of omics data. Additionally, functional validation of predicted pathways is often limited, making it challenging to conclusively link gene clusters or metabolites to specific pathogenic outcomes. Finally, while meta-analytic approaches provide pooled estimates, they cannot fully capture the dynamic interactions between fungi and hosts under variable environmental conditions. Future research integrating longitudinal, experimental, and in vivo studies is necessary to validate multi-omics findings and better understand the ecological and pathogenic versatility of Diaporthe species.

6. Conclusion

This systematic review and meta-analysis highlight the molecular adaptability of Diaporthe species, revealing conserved gene clusters, dynamic transcriptomic responses, and bioactive metabolites. Multi-omics approaches provide critical insights into fungal pathogenicity, host interactions, and biotechnological potential, offering a foundation for disease mitigation and novel therapeutic discovery.

 

References


Ahmed, I., Roy, B. C., Khan, S. A., Septer, S., & Umar, S. (2016). Microbiome, metabolome and inflammatory bowel disease. Microorganisms, 4(2), 20. https://doi.org/10.3390/microorganisms4020020

Alves, V., Zamith-Miranda, D., Frases, S., & Nosanchuk, J. D. (2025). Fungal metabolomics: A comprehensive approach to understanding pathogenesis in humans and identifying potential therapeutics. Journal of Fungi, 11(2), 93. https://doi.org/10.3390/jof11020093

Aujoulat, F., Roger, F., Bourdier, A., Lotthé, A., Lamy, B., Marchandin, H., & Jumas-Bilak, E. (2012). From environment to man: Genome evolution and adaptation of human opportunistic bacterial pathogens. Genes, 3(2), 191-232. https://doi.org/10.3390/genes3020191

Becker, Y., Eaton, C. J., Brasell, E., May, K. J., Becker, M., Hassing, B., ... & Scott, B. (2015). The fungal cell-wall integrity MAPK cascade is crucial for hyphal network formation and maintenance of restrictive growth of Epichloë festucae in symbiosis with Lolium perenne. Molecular Plant-Microbe Interactions, 28(1), 69-85. https://doi.org/10.1094/MPMI-06-14-0170-R

Bills, G. F., & Gloer, J. B. (2016). Biologically active secondary metabolites from the fungi. Microbiology Spectrum, 4(6). https://doi.org/10.1128/microbiolspec.funk-0009-2016

Boussau, B., Karlberg, E. O., Frank, A. C., Legault, B. A., & Andersson, S. G. (2004). Computational inference of scenarios for alpha-proteobacterial genome evolution. PNAS, 101(26), 9722-9727. https://doi.org/10.1073/pnas.0400975101

Brazilian National Genome Project Consortium. (2003). The complete genome sequence of Chromobacterium violaceum reveals remarkable and exploitable bacterial adaptability. PNAS, 100(20), 11660-11665. https://doi.org/10.1073/pnas.1832124100

Chepkirui, C., & Stadler, M. (2017). The genus Diaporthe: A rich source of diverse and bioactive metabolites. Mycological Progress, 16, 477-494. https://doi.org/10.1007/s11557-017-1288-y

Cheng, S. C., van de Veerdonk, F., Smeekens, S., Joosten, L. A., van der Meer, J. W., Kullberg, B. J., & Netea, M. G. (2010). Candida albicans dampens host defense by downregulating IL-17 production. The Journal of Immunology, 185(4), 2450-2457. https://doi.org/10.4049/jimmunol.1000355

Chisholm, S. T., Coaker, G., Day, B., & Staskawicz, B. J. (2006). Host-microbe interactions: Shaping the evolution of the plant immune response. Cell, 124(4), 803-814. https://doi.org/10.1016/j.cell.2006.02.008

Crotti, E., Rizzi, A., Chouaia, B., Ricci, I., Favia, G., Alma, A., ... & Cherif, A. (2010). Acetic acid bacteria, newly emerging symbionts of insects. Applied and Environmental Microbiology, 76(20), 6963-6970. https://doi.org/10.1128/AEM.01336-10

Dadachova, E., & Casadevall, A. (2008). Ionizing radiation: How fungi cope, adapt, and exploit with the help of melanin. Current Opinion in Microbiology, 11(6), 525-531. https://doi.org/10.1016/j.mib.2008.09.013

Darfeuille-Michaud, A., Boudeau, J., Bulois, P., Neut, C., Glasser, A. L., Barnich, N., ... & Colombel, J. F. (2004). High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology, 127(2), 412-421. https://doi.org/10.1053/j.gastro.2004.04.061

Devkota, S., Wang, Y., Musch, M. W., Leone, V., Fehlner-Peach, H., Nadimpalli, A., ... & Chang, E. B. (2012). Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10−/− mice. Nature, 487(7405), 104-108. https://doi.org/10.1038/nature11225

Dighton, J., Tugay, T., & Zhdanova, N. (2008). Fungi and ionizing radiation from radionuclides. FEMS Microbiology Letters, 281(2), 109-120. https://doi.org/10.1111/j.1574-6968.2008.01076.x

Ellinghaus, D., Bethune, J., Petersen, B. S., & Franke, A. (2015). The genetics of Crohn’s disease and ulcerative colitis—Status quo and beyond. Scandinavian Journal of Gastroenterology, 50(1), 13-23. https://doi.org/10.3109/00365521.2014.981329

Fang, X., Qin, K., Li, S., Han, S., & Zhu, T. (2020). Whole genome sequence of Diaporthe capsici, a new pathogen of walnut blight. Genomics, 112(5), 3751-3761. https://doi.org/10.1016/j.ygeno.2020.03.016

Fiocchi, C. (2012). Genes and ”in-vironment”: How will our concepts on the pathophysiology of inflammatory bowel disease develop in the future? Digestive Diseases, 30(1), 2-11. https://doi.org/10.1159/000341117

Gomes, R. R., Glienke, C., Videira, S. I., Lombard, L., Groenewald, J. Z., & Crous, P. W. (2013). Diaporthe: A genus of endophytic, saprobic and plant pathogenic fungi. Persoonia, 31, 1-41. https://doi.org/10.3767/003158513X666844

Goodwin, S., McPherson, J. D., & McCombie, W. R. (2016). Coming of age: Ten years of next-generation sequencing technologies. Nature Reviews Genetics, 17(6), 333-351. https://doi.org/10.1038/nrg.2016.49

Hilário, S., & Gonçalves, M. F. M. (2023). Mechanisms underlying the pathogenic and endophytic lifestyles in Diaporthe: An omics-based approach. Horticulturae, 9(4), 423. https://doi.org/10.3390/horticulturae9040423

Hilário, S., Gonçalves, M. F. M., Fidalgo, C., Tacão, M., & Alves, A. (2022). Genome analyses of two blueberry pathogens: Diaporthe amygdali CAA958 and Diaporthe eres CBS 160.32. Journal of Fungi, 8(8), 804. https://doi.org/10.3390/jof8080804

Hosseini, B., Voegele, R. T., & Link, T. I. (2020). Establishment of a quadruplex real-time PCR assay to distinguish the fungal pathogens Diaporthe longicolla, D. caulivora, D. eres, and D. novem on soybean. PLoS ONE, 16(10), e0257225. https://doi.org/10.1371/journal.pone.0257225

Janda, J. M., & Abbott, S. L. (2010). The genus Aeromonas: Taxonomy, pathogenicity, and infection. Clinical Microbiology Reviews, 23(1), 35-73. https://doi.org/10.1128/CMR.00039-09

Jansson, J., Willing, B., Lucio, M., Fekete, A., Dicksved, J., Halfvarson, J., ... & Schmitt-Kopplin, P. (2009). Metabolomics reveals metabolic biomarkers of Crohn’s disease. PLoS ONE, 4(7), e6386.

Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., Chou, R., Glanville, J., Grimshaw, J. M., Hróbjartsson, A., Lalu, M. M., Li, T., Loder, E. W., Mayo-Wilson, E., McDonald, S., … Moher, D. (2021). The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ, 372, n71.  https://doi.org/10.1136/bmj.n71  


Article metrics
View details
0
Downloads
0
Citations
1
Views

View Dimensions


View Plumx


View Altmetric



0
Save
0
Citation
1
View
0
Share